72 related articles for article (PubMed ID: 34535516)
41. On the new post COVID-19 condition.
Soriano JB; Ancochea J
Arch Bronconeumol; 2021 Dec; 57(12):735-736. PubMed ID: 34703072
[No Abstract] [Full Text] [Related]
42. Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.
Terlizzi K; Kutscher E; Yoncheva Y
J Am Board Fam Med; 2021; 34(5):1014-1016. PubMed ID: 34535527
[TBL] [Abstract][Full Text] [Related]
43. Characterising long COVID: a living systematic review.
Michelen M; Manoharan L; Elkheir N; Cheng V; Dagens A; Hastie C; O'Hara M; Suett J; Dahmash D; Bugaeva P; Rigby I; Munblit D; Harriss E; Burls A; Foote C; Scott J; Carson G; Olliaro P; Sigfrid L; Stavropoulou C
BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34580069
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India).
Sanches PRS; Charlie-Silva I; Braz HLB; Bittar C; Freitas Calmon M; Rahal P; Cilli EM
J Virus Erad; 2021 Sep; 7(3):100054. PubMed ID: 34548928
[TBL] [Abstract][Full Text] [Related]
45. Association between Long COVID and Overweight/Obesity.
Vimercati L; De Maria L; Quarato M; Caputi A; Gesualdo L; Migliore G; Cavone D; Sponselli S; Pipoli A; Inchingolo F; Scarano A; Lorusso F; Stefanizzi P; Tafuri S
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575251
[TBL] [Abstract][Full Text] [Related]
46. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
Marc A; Kerioui M; Blanquart F; Bertrand J; Mitjà O; Corbacho-Monné M; Marks M; Guedj J
Elife; 2021 Sep; 10():. PubMed ID: 34569939
[TBL] [Abstract][Full Text] [Related]
47. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
Wild JM; Porter JC; Molyneaux PL; George PM; Stewart I; Allen RJ; Aul R; Baillie JK; Barratt SL; Beirne P; Bianchi SM; Blaikley JF; Brooke J; Chaudhuri N; Collier G; Denneny EK; Docherty A; Fabbri L; Gibbons MA; Gleeson FV; Gooptu B; Hall IP; Hanley NA; Heightman M; Hillman TE; Johnson SR; Jones MG; Khan F; Lawson R; Mehta P; Mitchell JA; Platé M; Poinasamy K; Quint JK; Rivera-Ortega P; Semple M; Simpson AJ; Smith D; Spears M; Spencer LG; Stanel SC; Thickett DR; Thompson AAR; Walsh SL; Weatherley ND; Weeks ME; Wootton DG; Brightling CE; Chambers RC; Ho LP; Jacob J; Piper Hanley K; Wain LV; Jenkins RG
BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34556492
[TBL] [Abstract][Full Text] [Related]
48. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
Hastie KM; Li H; Bedinger D; Schendel SL; Dennison SM; Li K; Rayaprolu V; Yu X; Mann C; Zandonatti M; Diaz Avalos R; Zyla D; Buck T; Hui S; Shaffer K; Hariharan C; Yin J; Olmedillas E; Enriquez A; Parekh D; Abraha M; Feeney E; Horn GQ; ; Aldon Y; Ali H; Aracic S; Cobb RR; Federman RS; Fernandez JM; Glanville J; Green R; Grigoryan G; Lujan Hernandez AG; Ho DD; Huang KA; Ingraham J; Jiang W; Kellam P; Kim C; Kim M; Kim HM; Kong C; Krebs SJ; Lan F; Lang G; Lee S; Leung CL; Liu J; Lu Y; MacCamy A; McGuire AT; Palser AL; Rabbitts TH; Rikhtegaran Tehrani Z; Sajadi MM; Sanders RW; Sato AK; Schweizer L; Seo J; Shen B; Snitselaar JL; Stamatatos L; Tan Y; Tomic MT; van Gils MJ; Youssef S; Yu J; Yuan TZ; Zhang Q; Peters B; Tomaras GD; Germann T; Saphire EO
Science; 2021 Oct; 374(6566):472-478. PubMed ID: 34554826
[TBL] [Abstract][Full Text] [Related]
49. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
[TBL] [Abstract][Full Text] [Related]
50. Post-acute sequelae of COVID-19: Evidence of mood & cognitive impairment.
Lamontagne SJ; Winters MF; Pizzagalli DA; Olmstead MC
Brain Behav Immun Health; 2021 Nov; 17():100347. PubMed ID: 34549199
[TBL] [Abstract][Full Text] [Related]
51. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail.
Dong J; Zost SJ; Greaney AJ; Starr TN; Dingens AS; Chen EC; Chen RE; Case JB; Sutton RE; Gilchuk P; Rodriguez J; Armstrong E; Gainza C; Nargi RS; Binshtein E; Xie X; Zhang X; Shi PY; Logue J; Weston S; McGrath ME; Frieman MB; Brady T; Tuffy KM; Bright H; Loo YM; McTamney PM; Esser MT; Carnahan RH; Diamond MS; Bloom JD; Crowe JE
Nat Microbiol; 2021 Oct; 6(10):1233-1244. PubMed ID: 34548634
[TBL] [Abstract][Full Text] [Related]
52. Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA.
Skidmore PT; Kaelin EA; Holland LA; Maqsood R; Wu LI; Mellor NJ; Blain JM; Harris V; LaBaer J; Murugan V; Lim ES
Emerg Infect Dis; 2021 Oct; 27(10):2718-2720. PubMed ID: 34545803
[TBL] [Abstract][Full Text] [Related]
53. SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.
Stirrup O; Boshier F; Venturini C; Guerra-Assunção JA; Alcolea-Medina A; Beckett A; Charalampous T; da Silva Filipe A; Glaysher S; Khan T; Kulasegaran Shylini R; Kele B; Monahan I; Mollett G; Parker M; Pelosi E; Randell P; Roy S; Taylor J; Weller S; Wilson-Davies E; Wade P; Williams R; ; ; Copas A; Cutino-Moguel MT; Freemantle N; Hayward AC; Holmes A; Hughes J; Mahungu T; Nebbia G; Partridge D; Pope C; Price J; Robson S; Saeed K; de Silva T; Snell L; Thomson E; Witney AA; Breuer J
BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34544733
[TBL] [Abstract][Full Text] [Related]
54. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
Schmidt F; Weisblum Y; Rutkowska M; Poston D; DaSilva J; Zhang F; Bednarski E; Cho A; Schaefer-Babajew DJ; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Nature; 2021 Dec; 600(7889):512-516. PubMed ID: 34544114
[TBL] [Abstract][Full Text] [Related]
55. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis.
Long Q; Li J; Hu X; Bai Y; Zheng Y; Gao Z
Front Med (Lausanne); 2021; 8():702635. PubMed ID: 34540862
[No Abstract] [Full Text] [Related]
56. Six-Month Quality of Life in COVID-19 Intensive Care Unit Survivors.
Likhvantsev V; Landoni G; Perekhodov S; Chaus N; Kadantseva K; Ermokhina L; Baeva A; Yadgarov M; Berikashvili L; Kuzovlev A; Grechko A
J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):1949-1955. PubMed ID: 34538745
[TBL] [Abstract][Full Text] [Related]
57. One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients.
González J; Zuil M; Benítez ID; de Gonzalo-Calvo D; Aguilar M; Santisteve S; Vaca R; Minguez O; Seck F; Torres G; de Batlle J; Gómez S; Barril S; Moncusí-Moix A; Monge A; Gort-Paniello C; Ferrer R; Ceccato A; Fernández L; Motos A; Riera J; Menéndez R; Garcia-Gasulla D; Peñuelas O; Labarca G; Caballero J; Barberà C; Torres A; Barbé F
Front Med (Lausanne); 2022; 9():897990. PubMed ID: 35911414
[TBL] [Abstract][Full Text] [Related]
58. The Impact of Initial COVID-19 Episode Inflammation Among Adults on Mortality Within 12 Months Post-hospital Discharge.
Mainous AG; Rooks BJ; Orlando FA
Front Med (Lausanne); 2022; 9():891375. PubMed ID: 35646997
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 Post-acute Sequelae Among Adults: 12 Month Mortality Risk.
Mainous AG; Rooks BJ; Wu V; Orlando FA
Front Med (Lausanne); 2021; 8():778434. PubMed ID: 34926521
[No Abstract] [Full Text] [Related]
60. Risk of New Hospitalization Post-COVID-19 Infection for Non-COVID-19 Conditions.
Mainous AG; Rooks BJ; Orlando FA
J Am Board Fam Med; 2021; 34(5):907-913. PubMed ID: 34535516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
